Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study

Author： Goldstein Barry J.   Weissman Peter N.   Wooddell Margaret J.   Waterhouse Brian R.   Cobitz Alexander R.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.9, 2006-09, pp. : 1715-1723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

By Weissman P.   Goldstein B. J.   Rosenstock J.   Waterhouse B.   Cobitz A. R.   Wooddell M. J.   Strow L. J.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2029-2035

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial

By Zeng Zhengpei  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 921-929

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1460-1469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 689-698

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 409-414

John Wiley & Sons Inc

Access to resources Recommend Favorite